Guardant Health
GH
#1618
Rank
A$19.18 B
Marketcap
A$147.74
Share price
-2.44%
Change (1 day)
164.48%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): A-$5.02

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$4.86. In 2024 the company made an earnings per share (EPS) of A-$5.39 an increase over its 2023 EPS that were of A-$6.48.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.02-6.96%
2024A-$5.39-16.82%
2023A-$6.48-33.13%
2022A-$9.6960%
2021A-$6.0655.04%
2020A-$3.91207.14%
2019A-$1.27-19.81%
2018A-$1.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
A-$3.24-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
A-$7.28 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA